InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
1
T+90 胜率
0%
T+90 平均收益
-54.5%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the detailed record of transactions filed by Wirth Peter, 董事. Director active across 3 companies, notably Forma Therapeutics Holdings, Inc.. In total, 13 reports have been logged. Breakdown: 2 buys · 1 sell. Total volume traded: €636k. History available since 17 June 2021. The latest transaction was disclosed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Wirth Peter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
10,831 股0American Depositary SharesSEC:0000905148-25-002221:0
21,253 股0American Depositary SharesSEC:0000905148-24-001752:0
4,000 股0Common StockSEC:0000950170-24-070708:0
18,903 股@ US$26.4534.1% 占其流量American Depositary SharesSEC:0000950170-23-031102:0
4,000 股0Common StockSEC:0001209191-23-033735:0
4,000 股@ US$71.3618.8% 占其流量American Depositary SharesSEC:0000899243-22-038230:0
标准退出：2022年3月8日 (T+90)
3,852 股@ US$35.379.6% 占其流量American Depositary SharesSEC:0000899243-22-038070:0
127,665 股Common StockSEC:0000899243-22-033648:0
8,000 股0Common StockSEC:0001209191-22-050561:0
4,500 股0Common StockSEC:0000899243-22-021664:0
7,763 股0Ordinary SharesSEC:0001567619-22-000400:0
4,000 股@ US$71.3630.0% 占其流量Ordinary SharesSEC:0001567619-21-021802:0
标准退出：2022年3月8日 (T+90)
2,750 股0Common StockSEC:0000899243-21-025089:0
13 条申报中的 13 条
About Wirth Peter
Peter Wirth is Administrateur at Zai Lab Ltd, Syros Pharmaceuticals, Inc. and Forma Therapeutics Holdings, Inc. He has 13 filings, and across the 13 sampled filings the buy and sell volumes are EUR 506256 and EUR 129594, with filings dated from 2021-06-21 to 2025-06-23; the most common transaction nature is Attribution.
